These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22451203)

  • 1. Dihydropyridine calcium channel blockers and the progression of parkinsonism.
    Marras C; Gruneir A; Rochon P; Wang X; Anderson G; Brotchie J; Bell CM; Fox S; Austin PC
    Ann Neurol; 2012 Mar; 71(3):362-9. PubMed ID: 22451203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.
    Schneeweiss S; Soumerai SB; Maclure M; Dormuth C; Walker AM; Glynn RJ
    Clin Pharmacol Ther; 2003 Oct; 74(4):388-400. PubMed ID: 14534526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K
    Hypertens Res; 2009 Apr; 32(4):270-5. PubMed ID: 19262495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dihydropyridine calcium-channel blockers for the treatment of hypertensive diabetic patients.
    Staessen JA; Birkenhäger WH; Fagard RH
    Eur Heart J; 2000 Jan; 21(1):2-7. PubMed ID: 10610733
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of combination therapy with angiotensin II type I receptor blockers and calcium channel blockers on renal function in hypertensive patients/a retrospective, "real-world" comparative study.
    Yamada H; Suga N; Maeda K; Kimura Y; Miura N; Futenma A; Imai H
    Arzneimittelforschung; 2010; 60(2):64-70. PubMed ID: 20329653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of calcium antagonists in hypertensive patients with renal dysfunction: a prospective, randomized, parallel trial comparing benidipine and nifedipine.
    Inoue S; Tomino Y
    Nephrology (Carlton); 2004 Oct; 9(5):265-71. PubMed ID: 15504138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-acting versus short-acting calcium channel blockers among older survivors of acute myocardial infarction.
    Gillman MW; Ross-Degnan D; McLaughlin TJ; Gao X; Spiegelman D; Hertzmark E; Goldman L; Soumerai SB
    J Am Geriatr Soc; 1999 May; 47(5):512-7. PubMed ID: 10323641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of new calcium channel blocker, azelnidipine, and amlodipine on baroreflex sensitivity and ambulatory blood pressure.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Fukuda T; Numao T; Shimada K; Kario K
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):394-400. PubMed ID: 17577104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year results of an open-label study on antiproteinuric effect of benidipine in elderly patients with chronic kidney disease.
    Tomino Y; Shimizu Y; Hamada C; Kurusu A; Ohsawa I; Suzuki Y; Tsuge T; Io H; Kobayashi N; Takeda Y; Asanuma K; Tanaka Y; Suzuki H; Nakata J; Takara K; Horikoshi S
    J Nephrol; 2011; 24(6):756-63. PubMed ID: 21360472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) study.
    Ohishi M; Takagi T; Ito N; Terai M; Tatara Y; Hayashi N; Shiota A; Katsuya T; Rakugi H; Ogihara T
    Hypertens Res; 2007 Sep; 30(9):797-806. PubMed ID: 18037772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of dihydropyridine calcium antagonists in hypertensive patients with impaired renal function.
    Hansson LH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 10():S36-9; discussion S59-62. PubMed ID: 2483570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of calcium channel blockers in hypertension.
    Conlin PR; Williams GH
    Adv Intern Med; 1998; 43():533-62. PubMed ID: 9506192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropyridines, felodipine, and PHARMAC.
    Mann S
    N Z Med J; 2005 Jul; 118(1218):U1569. PubMed ID: 16027743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of oxodipine, a novel dihydropyridine calcium channel blocker, in neurogenic hypertensive dogs.
    Montastruc P; Montastruc JL; Dubreuil J; Galiano A
    Arch Int Pharmacodyn Ther; 1993; 321():57-62. PubMed ID: 8323416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of high doses of lercanidipine versus high doses of other dihydropyridines in daily clinical practice: the TOLERANCE Study.
    Barrios V; Escobar C; de la Figuera M; Llisterri JL; Honorato J; Segura J; Calderón A
    Cardiovasc Ther; 2008; 26(1):2-9. PubMed ID: 18466416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of ionizing radiation of 1,4-dihydropyridine derivatives in the solid state.
    Naskrent M; Mielcarek J
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 May; 67(1):251-5. PubMed ID: 16987696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species and antioxidant status in essential arterial hypertension during therapy with dihydropyridine calcium channel antagonists.
    Digiesi V; Fiorillo C; Cosmi L; Rossetti M; Lenuzza M; Guidi D; Pace S; Rizzuti G; Nassi P
    Clin Ter; 2000; 151(1):15-8. PubMed ID: 10822876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of lercanidipine versus other calcium channel blockers in newly diagnosed hypertension: a nationwide cohort study.
    Cheng KH; Cheng KC; Cheng KY; Yang YH; Lee CW; Lai WT
    Curr Med Res Opin; 2017 Jun; 33(6):1111-1117. PubMed ID: 28300435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of benidipine hydrochloride, a long-acting T-type calcium channel blocker, on blood pressure and renal function in hypertensive patients with diabetes mellitus. Analysis after switching from cilnidipine to benidipine.
    Seino H; Miyaguchi S; Yamazaki T; Ota S; Yabe R; Suzuki S
    Arzneimittelforschung; 2007; 57(8):526-31. PubMed ID: 17915639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.